πŸ‡ΊπŸ‡Έ FDA
Patent

US 8697709

Fused ring heteroaryl kinase inhibitors

granted A61KA61K31/519A61P

Quick answer

US patent 8697709 (Fused ring heteroaryl kinase inhibitors) held by The Regents of the University of California expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/519, A61P, A61P35/00, A61P35/02